Comprehensive plasma acylcarnitine profiles of type 2 diabetic and non‐diabetic subjects with or without an uncoupling protein 3 (UCP3) missense polymorphism

MLA

Kerry H. Lok, et al. “Comprehensive Plasma Acylcarnitine Profiles of Type 2 Diabetic and Non‐diabetic Subjects with or without an Uncoupling Protein 3 (UCP3) Missense Polymorphism.” The FASEB Journal, vol. 22, Mar. 2008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........de7d320d85b3293b18155528e938af35&authtype=sso&custid=ns315887.

APA

Kerry H. Lok, Charles L. Hoppel, John W. Newman, W. Timothy Garvey, & Sean H. Adams. (2008). Comprehensive plasma acylcarnitine profiles of type 2 diabetic and non‐diabetic subjects with or without an uncoupling protein 3 (UCP3) missense polymorphism. The FASEB Journal, 22.

Chicago

Kerry H. Lok, Charles L. Hoppel, John W. Newman, W. Timothy Garvey, and Sean H. Adams. 2008. “Comprehensive Plasma Acylcarnitine Profiles of Type 2 Diabetic and Non‐diabetic Subjects with or without an Uncoupling Protein 3 (UCP3) Missense Polymorphism.” The FASEB Journal 22 (March). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........de7d320d85b3293b18155528e938af35&authtype=sso&custid=ns315887.